Cite
HARVARD Citation
Cooles, F. et al. (2016). Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapies. Arthritis research & therapy. 18 (1), pp. 1-11. [Online].